Log in to save to my catalogue

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6374819

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

About this item

Full title

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

BioMed research international, 2019-01, Vol.2019 (2019), p.1-9

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

We have determined patient’s amyloid subtype through immunohistochemical and proteomic analyses of formalin-fixed, paraffin-embedded (FFPE) tissue samples from two affected organs per patient. Amyloid typing, via immunohistochemistry (IHC) and laser microdissection followed by the combination of liquid chromatography with mass spectrometry (LMD-LC-...

Alternative Titles

Full title

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6374819

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6374819

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2019/3689091

How to access this item